 Benjamin Kopecky
Concepts (154)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ear, Inner | 5 | 2013 | 39 | 1.360 |
Why?
| | Heart Transplantation | 4 | 2023 | 671 | 1.270 |
Why?
| | Organ of Corti | 7 | 2013 | 14 | 1.240 |
Why?
| | Macrophages | 7 | 2023 | 1282 | 1.140 |
Why?
| | Proto-Oncogene Proteins c-myc | 2 | 2013 | 115 | 0.800 |
Why?
| | Hair Cells, Auditory | 6 | 2013 | 39 | 0.750 |
Why?
| | Microscopy, Confocal | 4 | 2013 | 299 | 0.680 |
Why?
| | Myocardium | 2 | 2023 | 929 | 0.660 |
Why?
| | Lung Transplantation | 1 | 2020 | 246 | 0.590 |
Why?
| | Cochlea | 4 | 2013 | 89 | 0.520 |
Why?
| | Genes, myc | 2 | 2012 | 47 | 0.480 |
Why?
| | Calcium Channels, T-Type | 1 | 2014 | 16 | 0.470 |
Why?
| | Cell Differentiation | 5 | 2023 | 1709 | 0.470 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 6 | 2020 | 226 | 0.460 |
Why?
| | Mice | 18 | 2023 | 15085 | 0.460 |
Why?
| | Hair Cells, Auditory, Inner | 2 | 2013 | 13 | 0.450 |
Why?
| | Calcium Channel Blockers | 1 | 2014 | 115 | 0.450 |
Why?
| | Ear | 3 | 2015 | 32 | 0.440 |
Why?
| | Neuroprotective Agents | 1 | 2014 | 105 | 0.440 |
Why?
| | Graft Rejection | 5 | 2023 | 533 | 0.430 |
Why?
| | Gait Ataxia | 1 | 2012 | 5 | 0.410 |
Why?
| | Regeneration | 2 | 2013 | 162 | 0.400 |
Why?
| | Vestibular Diseases | 1 | 2012 | 22 | 0.400 |
Why?
| | Animals | 23 | 2023 | 32158 | 0.390 |
Why?
| | Vestibule, Labyrinth | 1 | 2012 | 54 | 0.380 |
Why?
| | Nervous System Diseases | 1 | 2014 | 253 | 0.380 |
Why?
| | Epithelium | 2 | 2011 | 297 | 0.370 |
Why?
| | Monocytes | 3 | 2023 | 504 | 0.360 |
Why?
| | Sensory Receptor Cells | 1 | 2011 | 78 | 0.360 |
Why?
| | Gene Deletion | 2 | 2011 | 356 | 0.360 |
Why?
| | Cerebellum | 1 | 2012 | 200 | 0.350 |
Why?
| | Imaging, Three-Dimensional | 1 | 2012 | 495 | 0.330 |
Why?
| | Heart | 3 | 2023 | 612 | 0.330 |
Why?
| | Tissue Donors | 2 | 2022 | 331 | 0.320 |
Why?
| | Cell Proliferation | 2 | 2013 | 2196 | 0.320 |
Why?
| | Hair Cells, Auditory, Outer | 2 | 2020 | 6 | 0.310 |
Why?
| | Homeostasis | 2 | 2023 | 577 | 0.300 |
Why?
| | Mice, Knockout | 6 | 2013 | 2608 | 0.290 |
Why?
| | In Situ Hybridization | 3 | 2013 | 298 | 0.230 |
Why?
| | Mice, Inbred C57BL | 5 | 2022 | 4779 | 0.220 |
Why?
| | Cyclosporine | 1 | 2023 | 169 | 0.210 |
Why?
| | Adipose Tissue, White | 1 | 2022 | 33 | 0.210 |
Why?
| | Interferon Type I | 1 | 2023 | 129 | 0.210 |
Why?
| | PAX2 Transcription Factor | 2 | 2013 | 6 | 0.200 |
Why?
| | Myeloid Differentiation Factor 88 | 1 | 2022 | 90 | 0.200 |
Why?
| | Organ Transplantation | 1 | 2023 | 161 | 0.190 |
Why?
| | Integrases | 2 | 2013 | 117 | 0.190 |
Why?
| | Signal Transduction | 2 | 2015 | 4527 | 0.190 |
Why?
| | Hearing Loss | 3 | 2015 | 183 | 0.180 |
Why?
| | Macrophage Activation | 1 | 2021 | 165 | 0.180 |
Why?
| | LIM Domain Proteins | 1 | 2020 | 13 | 0.180 |
Why?
| | LIM-Homeodomain Proteins | 1 | 2020 | 14 | 0.180 |
Why?
| | Immunohistochemistry | 3 | 2013 | 1644 | 0.180 |
Why?
| | Gait | 2 | 2013 | 249 | 0.170 |
Why?
| | Ventricular Remodeling | 1 | 2021 | 225 | 0.170 |
Why?
| | Nerve Tissue Proteins | 3 | 2012 | 537 | 0.170 |
Why?
| | Antioxidants | 1 | 2022 | 534 | 0.160 |
Why?
| | Myocardial Reperfusion Injury | 1 | 2019 | 93 | 0.160 |
Why?
| | Cardiomyopathy, Dilated | 1 | 2021 | 352 | 0.160 |
Why?
| | Neovascularization, Physiologic | 1 | 2018 | 174 | 0.140 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2020 | 377 | 0.140 |
Why?
| | Hearing | 2 | 2015 | 132 | 0.140 |
Why?
| | Humans | 14 | 2023 | 115859 | 0.130 |
Why?
| | Kidney Transplantation | 1 | 2022 | 559 | 0.130 |
Why?
| | Embryo, Mammalian | 2 | 2012 | 215 | 0.120 |
Why?
| | Myocytes, Cardiac | 1 | 2019 | 457 | 0.120 |
Why?
| | Morpholines | 1 | 2015 | 103 | 0.120 |
Why?
| | Gene Expression Regulation, Developmental | 4 | 2012 | 796 | 0.120 |
Why?
| | Vertebrates | 1 | 2013 | 56 | 0.100 |
Why?
| | Phenylurea Compounds | 1 | 2013 | 83 | 0.100 |
Why?
| | Evoked Potentials, Auditory, Brain Stem | 1 | 2013 | 52 | 0.100 |
Why?
| | ErbB Receptors | 1 | 2015 | 557 | 0.100 |
Why?
| | Transcription Factors | 1 | 2020 | 1535 | 0.100 |
Why?
| | Acoustic Stimulation | 1 | 2013 | 312 | 0.100 |
Why?
| | Cochlear Duct | 1 | 2011 | 1 | 0.100 |
Why?
| | Morphogenesis | 1 | 2012 | 161 | 0.090 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 935 | 0.090 |
Why?
| | Genotype | 2 | 2013 | 1830 | 0.090 |
Why?
| | Organ Specificity | 1 | 2011 | 274 | 0.090 |
Why?
| | Mice, Mutant Strains | 2 | 2021 | 271 | 0.090 |
Why?
| | Gene Transfer Techniques | 1 | 2011 | 149 | 0.090 |
Why?
| | Neoplasms | 1 | 2023 | 2114 | 0.080 |
Why?
| | Quality of Life | 1 | 2020 | 2390 | 0.080 |
Why?
| | Biological Evolution | 1 | 2013 | 418 | 0.080 |
Why?
| | Cell Cycle | 1 | 2011 | 546 | 0.080 |
Why?
| | Cardiovascular Diseases | 1 | 2018 | 1724 | 0.070 |
Why?
| | Stem Cell Transplantation | 1 | 2008 | 151 | 0.070 |
Why?
| | Computer Simulation | 1 | 2011 | 882 | 0.070 |
Why?
| | Stem Cells | 1 | 2011 | 546 | 0.070 |
Why?
| | Genetic Therapy | 1 | 2008 | 267 | 0.070 |
Why?
| | Bone Morphogenetic Protein 4 | 2 | 2020 | 34 | 0.070 |
Why?
| | Time Factors | 2 | 2013 | 6182 | 0.060 |
Why?
| | Antineoplastic Agents | 1 | 2015 | 1891 | 0.060 |
Why?
| | Mutation | 3 | 2021 | 3371 | 0.060 |
Why?
| | Starch | 1 | 2022 | 20 | 0.050 |
Why?
| | Lymphocytes, Tumor-Infiltrating | 1 | 2023 | 107 | 0.050 |
Why?
| | Receptor, Angiotensin, Type 1 | 1 | 2022 | 21 | 0.050 |
Why?
| | Transplantation, Homologous | 1 | 2023 | 397 | 0.050 |
Why?
| | Angiotensin Receptor Antagonists | 1 | 2022 | 77 | 0.050 |
Why?
| | Troponin T | 1 | 2021 | 49 | 0.050 |
Why?
| | Diet, High-Fat | 1 | 2022 | 225 | 0.050 |
Why?
| | Adipocytes | 1 | 2022 | 187 | 0.050 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 1 | 2022 | 180 | 0.050 |
Why?
| | Tumor Microenvironment | 1 | 2023 | 424 | 0.050 |
Why?
| | Sulfonamides | 1 | 2023 | 447 | 0.040 |
Why?
| | Fatty Acids | 1 | 2022 | 386 | 0.040 |
Why?
| | SOXB1 Transcription Factors | 1 | 2020 | 60 | 0.040 |
Why?
| | Receptors, CCR2 | 1 | 2019 | 28 | 0.040 |
Why?
| | Stroke Volume | 1 | 2022 | 510 | 0.040 |
Why?
| | Molecular Imaging | 1 | 2019 | 52 | 0.040 |
Why?
| | Evolution, Molecular | 2 | 2013 | 442 | 0.040 |
Why?
| | Cell Survival | 2 | 2012 | 1024 | 0.040 |
Why?
| | Ventricular Function, Left | 1 | 2022 | 469 | 0.040 |
Why?
| | Immunity, Innate | 1 | 2023 | 735 | 0.040 |
Why?
| | Positron-Emission Tomography | 1 | 2019 | 285 | 0.040 |
Why?
| | Mitochondria | 1 | 2022 | 749 | 0.040 |
Why?
| | Mice, Inbred CBA | 1 | 2015 | 56 | 0.030 |
Why?
| | Neuregulin-1 | 1 | 2015 | 41 | 0.030 |
Why?
| | Electrophysiology | 1 | 2015 | 202 | 0.030 |
Why?
| | Drug Screening Assays, Antitumor | 1 | 2015 | 180 | 0.030 |
Why?
| | Cell Movement | 1 | 2019 | 867 | 0.030 |
Why?
| | Female | 4 | 2015 | 60070 | 0.030 |
Why?
| | Spiral Ganglion | 1 | 2013 | 2 | 0.030 |
Why?
| | Developmental Biology | 1 | 2013 | 18 | 0.030 |
Why?
| | Male | 3 | 2015 | 56103 | 0.030 |
Why?
| | Transcription Factor Brn-3C | 1 | 2012 | 1 | 0.030 |
Why?
| | Stereocilia | 1 | 2012 | 8 | 0.030 |
Why?
| | Genes, Lethal | 1 | 2012 | 25 | 0.030 |
Why?
| | Gene Knock-In Techniques | 1 | 2012 | 47 | 0.030 |
Why?
| | DNA Mutational Analysis | 1 | 2013 | 378 | 0.020 |
Why?
| | Zebrafish | 1 | 2015 | 412 | 0.020 |
Why?
| | Microscopy, Electron, Scanning | 1 | 2012 | 194 | 0.020 |
Why?
| | Myosins | 1 | 2012 | 126 | 0.020 |
Why?
| | Organogenesis | 1 | 2012 | 55 | 0.020 |
Why?
| | Fibroblast Growth Factor 10 | 1 | 2010 | 24 | 0.020 |
Why?
| | Mechanotransduction, Cellular | 1 | 2012 | 96 | 0.020 |
Why?
| | GATA3 Transcription Factor | 1 | 2010 | 25 | 0.020 |
Why?
| | Obesity | 1 | 2022 | 2523 | 0.020 |
Why?
| | Animals, Newborn | 1 | 2012 | 780 | 0.020 |
Why?
| | Phylogeny | 1 | 2013 | 806 | 0.020 |
Why?
| | Repressor Proteins | 1 | 2012 | 369 | 0.020 |
Why?
| | Homeodomain Proteins | 1 | 2012 | 465 | 0.020 |
Why?
| | Alleles | 1 | 2010 | 817 | 0.020 |
Why?
| | Adult Stem Cells | 1 | 2008 | 32 | 0.020 |
Why?
| | Ethics, Medical | 1 | 2008 | 70 | 0.020 |
Why?
| | Pluripotent Stem Cells | 1 | 2008 | 63 | 0.020 |
Why?
| | Embryonic Stem Cells | 1 | 2008 | 105 | 0.020 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 1 | 2015 | 964 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2012 | 1971 | 0.020 |
Why?
| | Cochlear Implants | 1 | 2008 | 93 | 0.020 |
Why?
| | Retrospective Studies | 1 | 2022 | 12615 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2012 | 3914 | 0.010 |
Why?
| | Lung Neoplasms | 1 | 2015 | 2206 | 0.010 |
Why?
| | Pregnancy | 1 | 2012 | 5555 | 0.010 |
Why?
|
|
Kopecky's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|